Fuller & Thaler Asset Management
IRMD icon

Fuller & Thaler Asset Management’s iRadimed IRMD Stock Holding History

Fuller & Thaler Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,000
Closed -$56K – 821
2015
Q4 		$56K Buy
+2,000
New +$56.5K ﹤0.01% 597

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

Fuller & Thaler Asset Management's IRMD Position: Q1 2016 in Review

Fuller & Thaler Asset Management sold out of iRadimed (IRMD) in Q1 2016, closing a stake of 2,000 shares — an estimated $56K sold.

Fuller & Thaler Asset Management first reported a position in IRMD in Q4 2015 and held it in 1 quarter. The position peaked at $56K in Q4 2015. 66 funds tracked by Wall St. Rank hold IRMD as of Q1 2016.

  • Fuller & Thaler Asset Management reported no remaining iRadimed position as of Q1 2016 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 2,000 iRadimed shares in Q1 2016, an estimated $56K.
  • Fuller & Thaler Asset Management first reported a position in iRadimed in Q4 2015 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's iRadimed position peaked at $56K in Q4 2015.
  • 66 funds tracked by Wall St. Rank held iRadimed as of Q1 2016.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2016, filed 12 May 2016.